webinar register page

Molecular DNA and RNA Profiling in the Management of Patients with Solid Tumors
This 60-minute educational session will allow you to learn about:
• The clinical role of DNA and RNA profiling in precision oncology
• Which tests to order and when
• Various molecular abnormalities in solid tumors
• Targeted and immune therapeutic relevance of detecting molecular abnormalities
• How to use molecular profiling in evidence-based treatment decisions
• When to use liquid biopsy vs tissue biopsy profiling

Specific tests included in the webinar discussion include:
• Solid Tumor Profile 434 gene (DNA)
• Solid Tumor Fusion/Expression Profile 60+ gene (RNA)
• NTRK 1/2/3


* Required information